Literature DB >> 12203942

Neurovascular disease, antioxidants and glycation in diabetes.

P J Dickinson1, A L Carrington, G S Frost, A J M Boulton.   

Abstract

People with diabetes are ten to fifteen times more likely to have a lower limb amputation (LLA) than non-diabetic individuals. Fifteen percent of people with diabetes will develop a foot ulcer during their lifetime, the rate of major amputation amongst diabetic individuals continues to rise, foot problems remain the commonest reason for diabetes-related hospitalisation and recurrence rates in patients with previous foot ulcers are 50% or more. Hyperglycaemia-induced oxidative stress has been shown to result in decreased nerve conduction velocity, and decreased endoneural blood flow-both precursors for neuropathy. Vitamin antioxidants have been shown to be effective therapy in experimental models in reducing free radical species and inhibiting the oxidative process in diabetes subjects. Little work has been published, however, regarding the dietary use of antioxidants from foods, and their specific effects on neurovascular disease and glycation within the diabetes population. Aetiological and prevention studies with dietary antioxidants from foods aimed at the complex nature of foot problems in diabetes are needed. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203942     DOI: 10.1002/dmrr.305

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  11 in total

1.  Testicular oxidative damage and role of combined antioxidant supplementation in experimental diabetic rats.

Authors:  Magda Mohasseb; Samia Ebied; Mona A H Yehia; Neveen Hussein
Journal:  J Physiol Biochem       Date:  2010-12-24       Impact factor: 4.158

2.  Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

Authors:  W Todd Cade
Journal:  Phys Ther       Date:  2008-09-18

3.  Effect of whole body vibration on skin blood flow and nitric oxide production.

Authors:  Paula K Johnson; J Brent Feland; A Wayne Johnson; Gary W Mack; Ulrike H Mitchell
Journal:  J Diabetes Sci Technol       Date:  2014-05-21

4.  Forty-eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas.

Authors:  Xieda Zhou; Liting Wu; Yan Chen; Huangmeng Xiao; Xiaoyu Huang; Yanbing Li; Haipeng Xiao; Xiaopei Cao
Journal:  J Diabetes Investig       Date:  2020-12-30       Impact factor: 4.232

5.  Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients.

Authors:  Maria Rosaria Rizzo; Raffaele Marfella; Michelangela Barbieri; Virginia Boccardi; Francesco Vestini; Biagio Lettieri; Silvestro Canonico; Giuseppe Paolisso
Journal:  Diabetes Care       Date:  2010-06-23       Impact factor: 19.112

6.  Factors associated with lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus: A case-control study.

Authors:  Qingge Gao; Binbin He; Chaoyu Zhu; Yuanyuan Xiao; Li Wei; Weiping Jia
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 7.  Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients.

Authors:  Hong Shen; Junrong Zhao; Ying Liu; Guangdong Sun
Journal:  J Diabetes Res       Date:  2018-07-19       Impact factor: 4.011

Review 8.  Update on the pathogenesis of diabetic neuropathy.

Authors:  Irina G Obrosova
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

Review 9.  A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers.

Authors:  Larissa Zaulyanov; Robert S Kirsner
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

10.  Ensete superbum ameliorates renal dysfunction in experimental diabetes mellitus.

Authors:  M S Sreekutty; S Mini
Journal:  Iran J Basic Med Sci       Date:  2016-01       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.